11-77211329-TG-TGG
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000260.4(MYO7A):c.6231dupG(p.Lys2078GlufsTer50) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000260.4 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYO7A | ENST00000409709.9 | c.6231dupG | p.Lys2078GlufsTer50 | frameshift_variant | Exon 45 of 49 | 1 | NM_000260.4 | ENSP00000386331.3 | ||
MYO7A | ENST00000458637.6 | c.6117dupG | p.Lys2040GlufsTer48 | frameshift_variant | Exon 45 of 49 | 1 | ENSP00000392185.2 | |||
MYO7A | ENST00000409619.6 | c.6084dupG | p.Lys2029GlufsTer50 | frameshift_variant | Exon 46 of 50 | 1 | ENSP00000386635.2 | |||
MYO7A | ENST00000458169.2 | c.3657dupG | p.Lys1220GlufsTer50 | frameshift_variant | Exon 25 of 29 | 1 | ENSP00000417017.2 | |||
MYO7A | ENST00000670577.1 | n.*803dupG | non_coding_transcript_exon_variant | Exon 28 of 32 | ENSP00000499323.1 | |||||
MYO7A | ENST00000670577 | n.*803dupG | 3_prime_UTR_variant | Exon 28 of 30 | ENSP00000499323.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:2
- -
For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 179745). This premature translational stop signal has been observed in individual(s) with autosomal recessive MYO7A-related conditions (PMID: 28944237, 29048421). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Lys2078Glufs*50) in the MYO7A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MYO7A are known to be pathogenic (PMID: 8900236, 25404053). -
Usher syndrome type 1 Pathogenic:1
Criteria applied: PVS1,PM2_SUP,PM3 -
Rare genetic deafness Pathogenic:1
The p.Lys2078fs variant in MYO7A has been previously reported in one individual with hearing loss. It has not been identified in large population studies. This variant is predicted to cause a frameshift, which alters the protein?s amino aci d sequence beginning at position 2078 and lead to a premature termination codon 50 amino acids downstream. This alteration is then predicted to lead to a trunca ted or absent protein. Truncating or loss of function variants in the MYO7A gen e are an established disease mechanism for Usher syndrome. In summary, this var iant meets our criteria to be classified as pathogenic for Usher syndrome in an autosomal recessive manner (http://personalizedmedicine.partners.org/Laboratory- For-Molecular-Medicine/). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at